The immunohistochemistry was employed to assess the effect of THC treatment on AD neuropathologic change through the evaluation of the protein expression of phospho-tau, ionized calcium-binding adaptor molecule (Iba1), neuronal nuclei (NeuN), CB1, and GSK-3β in hippocampi. Here, RBFOX3 is linked to Alzheimer disease.